NR3C1 and breast carcinoma: The expression of NR3C1 in all breast cancer patients is shown in Figure 2A. We have found a low expression of NR3C1 in metastatic and grade III patients as compared to non-metastatic and grade II patients, respectively (Figure 2B,C).